Medicine

All Articles

Prenatal visibility to starvation influences lifetime health and wellness

.Nature Medication, Published online: 09 September 2024 doi:10.1038/ d41591-024-00068-4Analysis of i...

An international metric of immune system health

.Attribute Medicine, Published online: 05 September 2024 doi:10.1038/ s41591-024-03210-4A research u...

Niacin, food items intake and cardiovascular effects

.Attribute Medicine, Published online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, meal...

Opportunities as well as difficulties for patient-reported result analysis in multimorbidity study and also technique

.Competing enthusiasms.S.E.H. acquires backing from the National Institute of Wellness and Treatment...

Hibernation science harnessed to manage obesity as well as modify metabolic rate

.Attributes Medication, Published online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy recogn...

CAR- T as well as mobile gene treatments are actually also expensive

.Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care ...

The WHO genomics plan of benefit fair implementation of human genomics for international wellness

.The magazine of the first draft of the human genome series in 20011 was observed by the advancement...

A time-stratified, case\u00e2 $ \"crossover research of warm direct exposure and perinatal mortality from 16 hospitals in sub-Saharan Africa

.Amongst 138,015 hospital-based individual childbirths in 4 sub-Saharan African nations, we monitore...

Advancing worldwide antibiotic research, progression and also gain access to #.\n\nMurray, C. J. L. et cetera. International trouble of microbial antimicrobial protection in 2019: a methodical analysis. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. In the direction of details commitments and also action in the response to antimicrobial resistance. Worldwide Frontrunners Team on Antimicrobial Resistance https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). World Wellness Company. That publishes listing of germs for which brand-new antibiotics are actually urgently needed to have. World Health Company https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Health And Wellness Institution. That microbial priority microorganisms list, 2024: bacterial microorganisms of public health value to guide analysis, progression and also methods to stop and regulate antimicrobial resistance. World Health and wellness Association https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative entry. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic resistance. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle.com Scholar\u00c2.\nPlanet Health And Wellness Company. 2023 antibacterial representatives in medical and also preclinical development: an outline and evaluation. Planet Health Association https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Customer review. May 19, 2016 \u00e2 $\" Taking on drug-resistant infections around the world: final document as well as recommendations. Customer Review on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outputs: files and briefing. Steer abdominal https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et cetera. Appearing the wall: a require collective action on antibiotics research and development. Boston Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Policy Brief 51: Exactly how can the EU help sustainable advancement as well as accessibility to effective prescription antibiotics? policy possibilities for existing as well as new medicines. European Observatory on Health And Wellness Equipments and also Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Anti-biotic use as well as resistance\u00e2 $\" showing the obvious. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Health Organization. 2021 AWaRe distinction. WHO get access to, watch, get, distinction of anti-biotics for evaluation and monitoring of making use of. Planet Wellness Institution https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Center for Health Condition Protection and Management. Antimicrobial resistance targets: just how can our company reach them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Globe Wellness Association. Shortage of development set to weaken antibiotic functionality as well as wellness increases. Planet Wellness Organization https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et al. How antimicrobial resistance is actually linked to temperature improvement: a summary of 2 intertwined international challenges. Int. J. Environ. Res. Hygienics 20, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial infections: our experts need to have critical action and also financial investment that pay attention to the weakest web link. PLoS Biol. 20, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Health Institution. Booster shot insurance coverage. Globe Wellness Association https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Disease deterrence and command in low-resource settings: the demand for the nearby, the contextual and the pragmatic. Affect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Challenges of implementing antimicrobial conservation resources in low to mid profit countries (LMICs). Affect. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A short history of the antibiotic period: trainings learned and also problems for the future. Front. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et al. Client accessibility in 14 high-income countries to brand-new antibacterials authorized due to the US Food and Drug Administration, European Medicines Firm, Japanese Pharmaceuticals and Medical Gadget Organization, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Health Company. 2021 anti-bacterial representatives in clinical and also preclinical advancement: a guide and analysis. Globe Wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Prescription antibiotics: the business economics need to support the science. Nature 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of innovation in antibacterial therapies. Biotechnology Development Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et al. Evaluating clinician use of next-generation antibiotics against resistant Gram-negative contaminations in united state healthcare facilities: a retrospective mate study. Ann. Trainee. Medication. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of technology in anti-bacterial therapeutics. Biotechnology Advancement Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A methodical review as well as essential evaluation of reward methods for exploration and progression of novel anti-biotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle Scholar\u00c2.\nWellness Emergency Situation Preparedness and also Feedback Authority. Trial and error of health care countermeasures. International Percentage https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). International Commission. Pre-draft proposition for an European collaboration under Horizon Europe One Wellness Antimicrobial Protection. International Compensation https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). International Prescription Antibiotic Trial And Error Relationship. Entasis Therapies and also the Global Anti-biotic Analysis &amp Development Partnership to cultivate a brand new treatment for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of market- as well as non-industry-sponsored medical tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Health And Wellness Organization. Variety of professional test enrollments through location, health condition, phase of development, grow older and sex of trial attendees (1999\u00e2 $ \"2022). World Health Company https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Worldwide Anti-biotic Trial And Error Alliance. NeoSept1: a research study to figure out the rank of existing and also brand new prescription antibiotics combos to address newborns that reside in health center with severe blood poisoning. ISRCTN computer system registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Public Health Agency of Canada. Authorities of Canada creates essential expenditure to fight antimicrobial resistance (AMR), Federal government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). International Antibiotic Research and Development Relationship. Japan government backing supports GARDP\u00e2 $ s attempts to respond to antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Structure. Novo Nordisk Structure partners with CARB-X to combat drug-resistant diseases. novo nordisk groundwork https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Health as well as Digital Exec Company. Study on taking AMR medical countermeasures to the marketplace. Publications Workplace of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Approximating the proper size of global pull incentives for antibacterial medicines. Health Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimensions a market entry perks for the development of brand-new antibiotics. Harvard Kennedy School https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Business incentives and antibiotic resistance: an intro to the antibiotic vulnerability bonus. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An ambitious USG evolved commitment for subscription-based buying of novel antimicrobials and also its own assumed return on investment. Center for Global Progression https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 Nov 2022). Towse, A. &amp Silverman Bonnifield, R. G7 investments in new antibiotics will repay \u00e2 $\" for everybody. Workplace of Health and wellness Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS improves struggle versus life-threatening contaminations following productive world-first pilot. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). US Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Action of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Payment. Reform of the EU pharmaceutical legalisation. International Percentage https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Compensation styles to attack market failures for antimicrobials: techniques consumed France, Germany, Sweden, the United Kingdom, and the USA. Wellness Policy 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Federation of Pharmaceutical Manufacturers and also Organizations. From resistance to strength: what could the potential antibiotic pipe seem like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Worldwide AMR R&ampD Center &amp Globe Health And Wellness Association. Incentivising the development of brand new antibacterial therapies: 2023 report card by the Worldwide AMR R&ampD Center and WHO. International AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK membership style for prescription antibiotics thought about productive? Lancet Germ 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unique stimulations for the progression and keeping the marketplace of antimicrobials. Politician https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, regional, and also national sources of little one death in 2000\u00e2 $ \"13, along with projections to inform post-2015 concerns: an updated systematic analysis. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et al. Anti-bacterial medication shortages from 2001 to 2013: effects for scientific application. Clin. Corrupt. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et al. The French reporting device for medicine deficiencies: explanation and fads from 2012 to 2018: an empirical retrospective study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et al. Assessment of that antibiotic consumption and access targets in 76 nations, 2000\u00e2 $ \"15: an analysis of pharmaceutical sales data. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Combating the fakes: tackling substandard and falsified medicines. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it acquiring easier to secure antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrican Culture for Research Laboratory Medication. Policy short as well as infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic usage for human use in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Medication. Contaminate. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial intake: analysis of core warehouses items to in-patient treatment health and wellness amenities coming from 2017 to 2019 in Uganda. Trop. Med. Affect. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et al. Varieties in the intake of antimicrobial medications in the European location, 2014\u00e2 $ \"2018: searchings for and also effects from ESAC-Net as well as That Europe. Face. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et cetera. Medication scarcity: sources, impact, as well as minimization approaches. Front. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Person accessibility in 14 high-income nations to brand-new antibacterials authorized due to the United States Fda, European Medicines Firm, Japanese Pharmaceuticals and also Medical Gadget Company, or Health Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et cetera. Forgotten prescription antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health and wellness advancement for global wellness. Br. Medication. J. 366, 15601 (2019 ).\nGoogle.com Scholar\u00c2.\nAMR Industry Partnership. The 2023 AMR Industry Partnership development questionnaire: production and the atmosphere. amr Market Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Invasion, D. &amp Gaule, P. Can clinical products be developed on a non-profit manner? Exploring product growth partnerships for disregarded diseases. Sci. Public law 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nSwaminathan, S. et cetera. Reboot biomedical R&ampD in the worldwide social passion. Attribute 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Condition Management as well as Protection. Africa CDC leads bold relocate to secure Africa\u00e2 $ s health and wellness future through making a 50 billion dollar clinical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Carnage, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Discussing public-health intellectual property licensing agreements to enhance access to health technologies: an insider\u00e2 $ s account. BMJ Chunk. Wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New organization styles for trial and error along with cost demands are actually needed to attain decent rates of medications. Br. Medication. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nCombating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator. Conservation and get access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Worldwide Antibiotic R &amp D Relationship. Shinogi, GARDP as well as CHAI announce site license and collaboration agreements to alleviate bacterial diseases by growing accessibility to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Business Collaboration. Leaving behind the lab: tracking the downtrend in AMR R&ampD experts. amr Market Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Wellness Ministers. G7 Health Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (twenty May 2022). G20. G20 phone call to activity on antimicrobial protection. G7G20 Files Data source https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). Global Coalition on Aging &amp Infectious Diseases Culture of United States. 2024 AMR preparedness mark progress report. Evaluating authorities activity on AMR policy. Global Coalition on Getting older https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items and Farming Association of the United Nations, United Nations Atmosphere Programme, Planet Wellness Institution &amp. World Organisation for Creature Health. International data source for tracking antimicrobial protection (AMR): nation self-assessment survey (TrACSS). WHO https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Van Katwyk, S. R. &amp Outterson K. Intro: AMR belongs in the pandemi...

Integrating liver endpoints in medical tests of cardiovascular and also kidney illness

.Attribute Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point ...